FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to new improved solid-state or solvent tigecycline compositions, and to methods for preparing said compositions.
EFFECT: tigecycline, proper carbohydrates and acid or buffer found in the composition provide both solid-state, and solvent stability that allows facilitating considerably the use of tigecycline in hospitals to ensure necessary operability of the hospital personnel in treatment of patients.
24 cl, 6 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FORMULATIONS FOR PARENTERAL DELIVERY OF COMPOUNDS AND USING THEM | 2007 |
|
RU2539387C2 |
| COMPOSITION FOR OPTICAL VISUALIZATION, METHOD OF ITS PRODUCTION AND USE | 2019 |
|
RU2802481C2 |
| TETRACYCLIN COMPOSITION | 2011 |
|
RU2647972C2 |
| METHOD FOR PRODUCING PHARMACEUTICAL EMULSION OF LACTULOSE | 2013 |
|
RU2555349C2 |
| STRAIN OF BACTERIUM RHODOCOCCUS RUBER AS DESTRUCTOR OF POLYCHLORINATED BIPHENYLS | 2003 |
|
RU2262531C2 |
| PHOTOSENSITISER AND METHOD OF ITS OBTAINING | 2013 |
|
RU2523380C1 |
| PHARMACEUTICAL PREPARATIVE FORM | 2004 |
|
RU2362560C2 |
| HEMOSTIMULANT AND PHARMACEUTICAL COMPOSITION AND METHOD FOR HEMOPOIESIS STIMULATION | 2011 |
|
RU2482869C1 |
| LIPOPEPTIDE COMPOSITION AND RELATED METHODS | 2010 |
|
RU2607526C2 |
| CHLORIDE SALT OF PEPTIDE TAT-NR2B9c COMPOSITION, BASED THEREON AND METHODS FOR PRODUCTION THEREOF | 2015 |
|
RU2707885C2 |
